A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models

about

A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models

Item

http://www.wikidata.org/entity/Q38646217

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

A novel composite formulation ...... and osteoarthritic pain models

@en

type

Item

label

A novel composite formulation ...... and osteoarthritic pain models

@en

prefLabel

A novel composite formulation ...... and osteoarthritic pain models

@en

P1476

A novel composite formulation ...... and osteoarthritic pain models

@en

P2093

Carlo Schievano

http://www.w3.org/2001/XMLSchema#string

Daniela Impellizzeri

http://www.w3.org/2001/XMLSchema#string

Domenico Britti

http://www.w3.org/2001/XMLSchema#string

Valeria Maria Morittu

http://www.w3.org/2001/XMLSchema#string

P2860

Managing Neuropathic Pain in Dogs

An overview of underlying causes and animal models for the study of age-related degenerative disorders of the spine and synovial joints

Systematic review of nonsteroidal anti-inflammatory drug-induced adverse effects in dogs

Animal models of osteoarthritis: classification, update, and measurement of outcomes

A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia

The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.

The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis.

Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain

Effect of analgesic therapy on clinical outcome measures in a randomized controlled trial using client-owned dogs with hip osteoarthritis

P2888

s12917-017-1151-z

P304

229

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12917-017-1151-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090955699

http://www.w3.org/2001/XMLSchema#string

P698

28768536

http://www.w3.org/2001/XMLSchema#string

P921

osteoarthritis

P932

5541643

http://www.w3.org/2001/XMLSchema#string